Download Sample
Author
Prem Kumar with profound experience and sound knowledge across a wide range of market forecasting methods, demand f.....
Povidone Iodine Market: By Product, By Application ), By End User and Region Forecast 2021-2032
Povidone Iodine Market: By Product, By Application ), By End User and Region Forecast 2021-2032
Report ID:35910
Published Date:Sep 2025
No of Pages:234
Format:
Povidone Iodine Market size was valued at US$ 169.2 billion in 2025 and is expected to reach US$ 242.9 billion by 2032, growing at a significant CAGR of 5.3% from 2026-2032. The market report gives a comprehensive outlook on povidone-iodine across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) based on product, application, end-user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition.
Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment hot spots) and market unmet needs (Product opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global povidone-iodine products. Key drivers for the market growth include an increase in the geriatric population, growth in disposable income, excellent performance properties of povidone-iodine, rise in demand for povidone-iodine in applications such as antiseptics & disinfectants, and high growth in emerging economies. However, the presence of substitutes is hindering the market growth.
Study Period
2026-2032Base Year
2025CAGR
5.3%Largest Market
North-AmericaFastest Growing Market
N/A
Povidone-iodine is a complex of the potent bactericidal agent iodine and the carrier molecule povidone. It is the most common iodophore, releasing iodine slowly and is effective against bacteria, fungi, viruses, protozoa, cists and spores in pre-operative site treatments, skin, periodontal and also in eye infections. It is an effective germicide. High dilutions are active in destroying, within fifteen seconds, the organisms commonly found in the mouth. It is effective in higher dilutions than the stock commercial preparations of the other common antiseptics. When povidone-iodine is used to prepare the oral mucosa for local anesthetic injection prior to dental procedures, the hazard of direct bacterial infection is removed almost completely.
North America accounted for larger revenue share in global povidone iodine market with considerable CAGR due to stringent regulations on surgical hand antiseptics, increase in number of trauma, dental, and maxillofacial and bariatric surgeries especially in U.S. Also, need for disinfectants and rise in awareness about hygiene are other factors responsible for market growth. In addition, Europe held considerable market share during predicted period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
5.3% |
|
By Product |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The povidone iodine market size was valued at US$ 169.2 billion in 2025 and is expected to reach US$ 242.9 billion by 2032, growing at a significant CAGR of 5.3% from 2026-2032.
The market key players are: Adani Pharmachem Private Limited. BASF SE Boai NKY Pharmaceuticals Ltd. Glide Chem Private Limited. Huangshan Bonsun Pharmaceuticals Co., Ltd. Lasa Supergenerics Limited. Medline Industries, Inc. N. Laboratories Pvt. Ltd. Samrat Pharmachem Limited. Shanghai Yuking Water Soluble Material Tech Co., Ltd.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Content Updated Date: Feb 2026
| 1.Executive Summary |
| 2.Global Povidone Iodine Market Introduction |
| 2.1.Global Povidone Iodine Market - Taxonomy |
| 2.2.Global Povidone Iodine Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Povidone Iodine Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Povidone Iodine Market Analysis, 2021 - 2025 and Forecast 2026- 2032 |
| 4.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Povidone Iodine Market By Product, 2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 5.1. Pharmaceutical Grade PVP-I |
| 5.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Industrial Grade PVP-I |
| 5.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Povidone Iodine Market By Application, 2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 6.1. Skin Sterilization |
| 6.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Infection Prevention |
| 6.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Instrument Sterilization |
| 6.3.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others (including Breeding AND Aquaculture) |
| 6.4.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Povidone Iodine Market By End User, 2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 7.1. Aquaculture |
| 7.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceuticals |
| 7.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Coatings |
| 7.3.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Petrochemicals |
| 7.4.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Povidone Iodine Market By Region, 2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2021 - 2025 and Forecast, 2026- 2032, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Povidone Iodine Market ,2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 9.1. Product Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Pharmaceutical Grade PVP-I |
| 9.1.2.Industrial Grade PVP-I |
| 9.2. Application Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Skin Sterilization |
| 9.2.2.Infection Prevention |
| 9.2.3.Instrument Sterilization |
| 9.2.4.Others (including Breeding AND Aquaculture) |
| 9.3. End User Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Aquaculture |
| 9.3.2.Pharmaceuticals |
| 9.3.3.Coatings |
| 9.3.4.Petrochemicals |
| 9.3.5.Others |
| 9.4. Country Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Povidone Iodine Market ,2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Pharmaceutical Grade PVP-I |
| 10.1.2.Industrial Grade PVP-I |
| 10.2. Application Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Skin Sterilization |
| 10.2.2.Infection Prevention |
| 10.2.3.Instrument Sterilization |
| 10.2.4.Others (including Breeding AND Aquaculture) |
| 10.3. End User Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Aquaculture |
| 10.3.2.Pharmaceuticals |
| 10.3.3.Coatings |
| 10.3.4.Petrochemicals |
| 10.3.5.Others |
| 10.4. Country Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Povidone Iodine Market ,2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Pharmaceutical Grade PVP-I |
| 11.1.2.Industrial Grade PVP-I |
| 11.2. Application Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Skin Sterilization |
| 11.2.2.Infection Prevention |
| 11.2.3.Instrument Sterilization |
| 11.2.4.Others (including Breeding AND Aquaculture) |
| 11.3. End User Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Aquaculture |
| 11.3.2.Pharmaceuticals |
| 11.3.3.Coatings |
| 11.3.4.Petrochemicals |
| 11.3.5.Others |
| 11.4. Country Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Povidone Iodine Market ,2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Pharmaceutical Grade PVP-I |
| 12.1.2.Industrial Grade PVP-I |
| 12.2. Application Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Skin Sterilization |
| 12.2.2.Infection Prevention |
| 12.2.3.Instrument Sterilization |
| 12.2.4.Others (including Breeding AND Aquaculture) |
| 12.3. End User Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Aquaculture |
| 12.3.2.Pharmaceuticals |
| 12.3.3.Coatings |
| 12.3.4.Petrochemicals |
| 12.3.5.Others |
| 12.4. Country Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Povidone Iodine Market ,2021 - 2025 and Forecast 2026- 2032 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Pharmaceutical Grade PVP-I |
| 13.1.2.Industrial Grade PVP-I |
| 13.2. Application Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Skin Sterilization |
| 13.2.2.Infection Prevention |
| 13.2.3.Instrument Sterilization |
| 13.2.4.Others (including Breeding AND Aquaculture) |
| 13.3. End User Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Aquaculture |
| 13.3.2.Pharmaceuticals |
| 13.3.3.Coatings |
| 13.3.4.Petrochemicals |
| 13.3.5.Others |
| 13.4. Country Analysis 2021 - 2025 and Forecast 2026- 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Adani Pharmachem Private Limited. |
| 14.2.2.BASF SE |
| 14.2.3.Boai NKY Pharmaceuticals Ltd. |
| 14.2.4.Glide Chem Private Limited. |
| 14.2.5.Huangshan Bonsun Pharmaceuticals Co., Ltd. |
| 14.2.6.Lasa Supergenerics Limited. |
| 14.2.7.Medline Industries, Inc. |
| 14.2.8.N. Laboratories Pvt. Ltd. |
| 14.2.9.Samrat Pharmachem Limited. |
| 14.2.10.Shanghai Yuking Water Soluble Material Tech Co., Ltd. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Prem Kumar with profound experience and sound knowledge across a wide range of market forecasting methods, demand forecasting, and pricing analysis, I am able to make precise projections. I have extensive practical knowledge in Time Series Analysis (TSA), Simple Linear Regression (SLR), Multiple Linear Regression (MLR), Seasonality & Trend Forecasting, and Forecasting Models for New Products, among others. Additionally, I have hands-on experience with tools such as Power BI and SQL. I am highly committed, self-motivated, and possess a strong entrepreneurial spirit. Over the past 8 years, my team and I have built a robust clientele in various sectors, including Packaging, Pharma, Medical Devices, Oil & Gas, and Chemicals & Materials. We have provided a wide range of services, from management consulting to market forecasting and survey-related projects. I am particularly proud to have provided consulting services to one of the industry’s leading COVID-19 vaccine manufacturers for a packaging-related project. In the packaging space, I have served clients across a range of segments, including packaging printing, consumer packaging, flexible packaging, rigid packaging, and pharmaceutical packaging, to name a few. I deeply appreciate the efforts of my team and am grateful to our clients for their continued trust.